Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.

Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.

Item
http://www.wikidata.org/entity/Q50548319
Μanagement of patients with hepatitis B and C before and after liver and kidney transplantationPegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center studyNanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infectionUse of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency.Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations.Hepatitis C virus infection in end-stage renal disease and kidney transplantation.Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies.New therapies for hepatitis C: considerations in patients with renal impairment.Pegylated Interferon Mono-Therapy of Chronic Hepatitis C in the Dialysis Population: Systematic Review and Meta-Analysis.Treatment of HCV in Renal Disease: Subtle Management Considerations in the Era of Direct-acting Antivirals.What are the management issues for hepatitis C in dialysis patients?: hepatitis C virus infection and its treatment in patients with end-stage renal disease.Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis.Hepatitis C and renal transplantation in era of new antiviral agents
P2860

Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.

Item
http://www.wikidata.org/entity/Q50548319
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Efficacy and safety of pegylat ...... sequentially treated cohorts.
@en
Efficacy and safety of pegylat ...... sequentially treated cohorts.
@nl
type
label
Efficacy and safety of pegylat ...... sequentially treated cohorts.
@en
Efficacy and safety of pegylat ...... sequentially treated cohorts.
@nl
prefLabel
Efficacy and safety of pegylat ...... sequentially treated cohorts.
@en
Efficacy and safety of pegylat ...... sequentially treated cohorts.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Efficacy and safety of pegylat ...... sequentially treated cohorts.
@en
P2093
P304
P31
P356
10.1053/J.AJKD.2013.03.037
P433
P478
P577
P698